Shamburg News · 8-K filed Oct 6, 2026, 4:06 PM EDT

Inovio Pharmaceuticals Amends Bylaws to Add Exclusive Forum Provisions

INO · INOVIO PHARMACEUTICALS, INC.

  • Other
  • Materiality: low

On October 6, 2026, the Board of Directors of Inovio Pharmaceuticals, Inc. approved and adopted an amendment to the Amended and Restated Bylaws, effective immediately. The amendment adds a new Article 12 designating the Court of Chancery of the State of Delaware as the exclusive forum for certain specified actions, and the federal district courts of the United States as the exclusive forum for Securities Act of 1933 claims, unless the Company consents otherwise. The full text is filed as Exhibit 3.1.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Items 5.03, 9.01, accession 0001193125-26-415555.

Written from the filing by Shamburg Markets. Figures are as reported by the company.